Astellas Pharma

Key Takeaways Strategic brand growth and expanded product indications are driving revenue and upward revisions in forecasts, particularly in key markets like the U.S. Cost optimization and in-house R&D enhancements aim to boost margins through improved efficiencies and reduced reliance on external partners. Astellas Pharma faces financial risks due to strategic brand dependency, potential revenue declines in the U.S. market, currency fluctuations, and increased expenses.